A three year follow up study to assess the rate of death and other diseases in patients with a long-term condition where the airways of the lungs become widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection (bronchiectasis)

Mortality and comorbidities in patients with bronchiectasis over a three-year follow-up

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN11243396

Enrollment

100

Registered

2021-11-23

Start date

2017-02-01

Completion date

Unknown

Last updated

2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Risk factors for mortality in patients with non-cystic fibrosis bronchiectasis Respiratory

Interventions

Prospective cohort study comprising 120 adult patients with non-cystic fibrosis bronchiectasis regularly treated at the specialized outpatient clinic of a university hospital between January 2017 and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis of bronchiectasis confirmed by chest HRCT, evaluated by two radiologists and two pulmonologists

Exclusion criteria

Exclusion criteria: Cystic fibrosis

Design outcomes

Primary

Measure	Time frame
Mortality measured using patient records at the end of the study	—

Secondary

Measure	Time frame
Quality of life measured using Euro quality-of-life five-domain three-level questionnaire (EQ-5D-3L) at the initial consultation	—

Countries

Brazil

Contacts

Public ContactRogerio Rufino

rrufino.uerj@gmail.com+55.21.986255240

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026